Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Research Article


 

Development of Alginate/Chitosan Microparticles for Dust Mite Allergen

Tittaya Suksamran, Praneet Opanasopit*, Theerasak Rojanarata and Tanasait Ngawhirunpat

Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand

For correspondence: E-mail: praneet@su.ac.th  Tel: +66-34-255800; Fax: +66-34-255801

Received: 17 November 2010                                                     Revised accepted: 11 April 2011

Tropical Journal of Pharmaceutical Research, June 2011; 10(3): 317-324  doi: 10.4314/tjpr.v10i3.8

Abstract

 

Purpose: To develop chitosan/alginate microparticles for the mucosal delivery of allergen from dust mite (Dermatophagoides pteronyssinus).

Methods: Chitosan/alginate microparticles were prepared by ionotropic gelation. The effects of polymer content, crosslinking agent, and preparation method on the physicochemical characteristics of the microparticles as well as their in vitro cytotoxicity were investigated.

Results:  The microparticles were small (1 - 17 µm) and spherical in shape. The highest allergen content (0.30 ± 0.07 mg/g) was obtained with 2.5 % initial allergen loading in chitosan- triphosphate (CS-TPP) microparticles. Sustained allergen release  (approx. 50 % over 24 h) was observed from alginate-coated chitosan microparticles. Allergen incorporation method and initial drug-loading could be varied to obtain optimum particle size with high allergen-loading and sustained release. The cytotoxicity of various microparticle formulations did not differ significantly (p > 0.05 ), as cell viability values were close to 100 %.

Conclusion:  This study indicates that alginate and alginate-coated chitosan microparticles are safe and can be further developed for mucosal allergen delivery.

 

Keywords: Alginate, Chitosan, Microparticle, Allergen delivery, Dust mite, Dermatophagoides pteronyssinus

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net